Document is current
Any future updates will be listed below
-
Authors
Diesch, Jeannine
Le Pannérer, Marguerite-Marie https://orcid.org/0000-0002-5779-8805
Winkler, René https://orcid.org/0000-0002-7570-0242
Casquero, Raquel
Muhar, Matthias
van der Garde, Mark
Maher, Michael
Herráez, Carolina Martínez https://orcid.org/0000-0003-4711-7225
Bech-Serra, Joan J.
Fellner, Michaela
Rathert, Philipp https://orcid.org/0000-0003-1477-136X
Brooks, Nigel
Zamora, Lurdes
Gentilella, Antonio https://orcid.org/0000-0002-6830-2086
de la Torre, Carolina https://orcid.org/0000-0001-9363-291X
Zuber, Johannes https://orcid.org/0000-0001-8810-6835
Götze, Katharina S.
Buschbeck, Marcus https://orcid.org/0000-0002-3218-4567
-
Funding
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (FJCI-2014-22983, BES-2016–077251, SAF2017-84301-P, PIE16/00011)
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (CD17/00084)
José Carreras Leukämie-Stiftung (DJCLS 14R/2018)
- License Information
-
More Information
Article History
Received: 21 November 2020
Accepted: 22 September 2021
First Online: 18 October 2021
Competing interests
: K.S.G. has received support for independent research from Celgene Corp. N.B. is an employee and stockholder in CellCentric, Ltd. The other authors declare no competing interests.
